This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Climatotherapy At The Dead Sea For Atopic Dermatitis

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2009 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
Information provided by:
Hadassah Medical Organization Identifier:
First received: July 6, 2009
Last updated: March 1, 2011
Last verified: July 2009
The purpose of this study is to evaluate the improvement in severity of Atopic Dermatitis and quality of life after 4 weeks of treatment in the Dead Sea.

Atopic Dermatitis

Study Type: Observational
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Official Title: Evaluation of the Efficacy of Dead Sea Climatotherapy on Atopic Dermatitis Patients.

Resource links provided by NLM:

Further study details as provided by Hadassah Medical Organization:

Estimated Enrollment: 50
Study Start Date: June 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: November 2009 (Final data collection date for primary outcome measure)
Before and after treatment
SCORAD of each patient before and after treatment.

Detailed Description:

28 days treatment period, sun exposure and possibly Dead Sea baths after an exact given plan, discontinuation of all local Cortisone preparations, unlimited use of maintenance drags, doctor visit twice a week, continuous checks by the nurse.

Determination of the SCORAD index by the same doctor on arrival and departure. Before and after the treatment, the patient will answer written questionnaires regarding quality of life.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Atopic Dermatitis patient.

Inclusion Criteria:

  • Minimum age of 18 years old

Exclusion Criteria:

  • Skin type - I
  • Psoriasis patient in addition to Atopic Dermatitis
  • Pregnancy
  • Past malignancy
  • Less then 2 weeks of treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01307150

Contact: Arik Tzukert, DMD +972-(0)2-6776095
Contact: Hadas Lemberg, PhD +972-(0)2-6777572

DMZ Clinic Not yet recruiting
Jerusalem, Israel
Contact: Marco Harari, Dr.    +972-(0)8-6689200   
Sponsors and Collaborators
Hadassah Medical Organization
Study Chair: Arie Ingber, MD. Hadassa Medical Organization IRB
  More Information

Responsible Party: Hasassah Medical Organization IRB, Israel Ministry of Health Identifier: NCT01307150     History of Changes
Other Study ID Numbers: SK09409-HMO-CTIL
Study First Received: July 6, 2009
Last Updated: March 1, 2011

Keywords provided by Hadassah Medical Organization:
Atopic Dermatitis
Dead Sea

Additional relevant MeSH terms:
Dermatitis, Atopic
Skin Diseases
Skin Diseases, Genetic
Genetic Diseases, Inborn
Skin Diseases, Eczematous
Hypersensitivity, Immediate
Immune System Diseases processed this record on September 19, 2017